A correlation analysis between DEPDC1B expression and the clinical parameters of patients with CCA revealed that DEPDC1B expression was significantly upregulated in patients with a more advanced tumor grade (P < 0.05, Figure 1A and Table 2); these findings were further verified by Spearman rank correlation analysis (Table S4). This evidence concerns the gene DEPDC1B and cholangiocarcinoma.